Bill
S 1189
IMMUNIZATIONS – Adds to existing law to establish provisions regarding limitation of distribution and waiver of immunity for certain human gene therapy products.
Bill S 1189 simplifies licensure for fiscal intermediaries, reducing costs and boosting efficiency, which may enhance service access for consumers in health care and social services.